J. Emmanuelli and J. C. Desenclos, Harm reduction interventions, behaviours and associated health outcomes in France, vol.100, p.16277629, 1996.

L. Degenhardt, B. M. Mathers, A. L. Wirtz, D. Wolfe, A. Kamarulzaman et al., What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries, Int J Drug Policy, vol.25, p.24113623, 2014.

P. K. Nelson, B. M. Mathers, B. Cowie, H. Hagan, D. Jarlais et al., Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews, Addiction, vol.378, p.22564041, 2011.

L. Wiessing, M. Ferri, B. Grady, M. Kantzanou, I. Sperle et al., Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention, PLoS One, vol.9, p.103345, 2014.

S. A. Mcdonald, S. J. Hutchinson, C. Schnier, A. Mcleod, and D. J. Goldberg, Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods, Epidemiol Infect, vol.142, pp.200-207, 2014.

S. A. Mcdonald, S. J. Hutchinson, P. R. Mills, S. M. Bird, C. Robertson et al., Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population, Epidemiol Infect, vol.138, pp.393-402, 2010.

J. Bruneau, G. Zang, M. Abrahamowicz, D. Jutras-aswad, M. Daniel et al., Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study, Clin Infect Dis, vol.58, p.24363333, 2014.

J. Grebely, K. A. Genoway, J. D. Raffa, G. Dhadwal, T. Rajan et al., Barriers associated with the treatment of hepatitis C virus infection among illicit drug users, Drug Alcohol Depend, vol.93, p.17997050, 2008.

P. Roux, L. Gall, J. M. Debrus, M. Protopopescu, C. Demoulin et al., Innovative communitybased educational face-to-face intervention to reduce HIV, HCV and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study, 2015.

S. Darke, W. Hall, A. Wodak, N. Heather, and J. Ward, Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index, Br J Addict, vol.87, p.1591524, 1992.

K. A. Bradley, A. F. Debenedetti, R. J. Volk, E. C. Williams, D. Frank et al., AUDIT-C as a brief screen for alcohol misuse in primary care, Alcohol Clin Exp Res, vol.31, p.17451397, 2007.

C. L. Fry and N. Lintzeris, Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ), Addiction, vol.98, p.12534421, 2003.

K. Page, M. D. Morris, J. A. Hahn, L. Maher, and M. Prins, Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention, Clin Infect Dis, p.57, 2013.

, , vol.2, pp.32-38

C. Whelan, C. Chambers, M. Chan, S. Thomas, G. Ramos et al., Why do homeless people use a mobile health unit in a country with universal health care?, J Prim Care Community Health, vol.1, p.23804366, 2010.

L. B. Currie, M. L. Patterson, A. Moniruzzaman, L. C. Mccandless, and J. M. Somers, Examining the relationship between health-related need and the receipt of care by participants experiencing homelessness and mental illness, BMC Health Serv Res, vol.14, p.404, 2014.

I. Daiski, The health bus: healthcare for marginalized populations, Policy Polit Nurs Pract, vol.6, p.16443957, 2005.

J. Hastings, D. Zulman, and S. Wali, UCLA mobile clinic project. J Health Care Poor Underserved, vol.18, p.17982203, 2007.

F. Vallejo, G. Barrio, M. T. Brugal, J. Pulido, C. Toro et al., High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes, J Epidemiol Community Health, vol.69, pp.599-603, 2015.

E. , European Monitoring Centre for Drugs and Drug Addiction, 2013.

A. Benyamina, The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users, Int J Gen Med, vol.7, p.25228817, 2014.

A. Seidenberg, T. Rosemann, and O. Senn, Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting, BMC Infect Dis, vol.13, p.23298178, 2013.

M. Rotily, S. Loubiere, J. Prudhomme, I. Portal, A. Tran et al.,

, Gastroenterol Clin Biol, vol.26, p.11981471, 2002.

D. Salmon-ceron, J. Cohen, M. Winnock, P. Roux, F. B. Sadr et al., Engaging HIV-HCV coinfected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France), BMC Health Serv Res, vol.12, p.59, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00687514

A. Charlebois, L. Lee, C. E. Mason, K. Powis, and J. , Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients, J Viral Hepat, vol.19, p.23121361, 2012.

M. Alavi, J. D. Raffa, G. D. Deans, C. Lai, M. Krajden et al., Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents, Liver Int, vol.34, p.24164865, 2014.

B. Fischer, J. Rehm, J. Patra, K. Kalousek, E. Haydon et al., Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users, Addiction, vol.101, p.17156175, 2006.

M. Jauffret-roustide, L. Strat, Y. Couturier, E. Thierry, D. Rondy et al., A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design, BMC Infect Dis, vol.9, p.113, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00663624

S. Darke, Self-report among injecting drug users: a review, Drug Alcohol Depend, vol.51, p.9787998, 1998.